Mary L Disis


Ontology type: schema:Person     


Person Info

NAME

Mary L

SURNAME

Disis

Publications in SciGraph latest 50 shown

  • 2018-12 SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-12 Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-12 Gene expression markers of Tumor Infiltrating Leukocytes in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2017-04 Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer in SEMINARS IN IMMUNOPATHOLOGY
  • 2017 HER2/neu in CANCER THERAPEUTIC TARGETS
  • 2016-12 Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 Clinical significance of tumor-infiltrating lymphocytes in breast cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-12 Concurrent SPECT/PET-CT imaging as a method for tracking adoptively transferred T-cells in vivo in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-11 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2016-04 A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-02 Erratum to: Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-12 CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Preliminary validation of nCounter PanCancer immune profiling of FFPE slides and pbmc in CITN-05, a CITN study of the immunological effects of an IDO1 inhibitor in patients with ovarian carcinoma in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Motolimod, a selective TLR8 agonist induces apoptosis in monocytic myeloid-derived suppressor cells (M-MDSC) in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2015-12 Preamble to the 2015 SITC immunotherapy biomarkers taskforce in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Persistent immunity after therapeutic vaccination targeting HER2/neu correlated with post-vaccination magnitude of interferon gamma Elispot responses in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-12 Vaccine targeting HIF1A in triple negative breast cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2014-08 Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice in BREAST CANCER RESEARCH AND TREATMENT
  • 2014-02 HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2013-11 Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Chemical carcinogens used to induce spontaneous tumors may suppress tumor specific T-cell immunity in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Optimization of ex vivo expansion of HER2 specific polyfunctional Th1/Th17 cells from HER2 vaccine primed PBMC in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Vaccination with pre-diagnostic tumor antigens but not established tumor antigens inhibits spontaneous tumorigenesis in TgMMTV-neu mice in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 Precision analysis of a whole blood T cell subset immunophenotyping assay in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-11 TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-08 Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2013-06 T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity in BREAST CANCER RESEARCH AND TREATMENT
  • 2013 HER2/neu in CANCER THERAPEUTIC TARGETS
  • 2011-12 SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2011-12 Defining the critical hurdles in cancer immunotherapy in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2011-03 Immunologic biomarkers as correlates of clinical response to cancer immunotherapy in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2010-12 Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2010-06 HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2010-01 Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2009-12 Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2009-01 Common adjuvant breast cancer therapies do not inhibit cancer vaccine induced T cell immunity in BREAST CANCER RESEARCH AND TREATMENT
  • 2008-12 His-tag ELISA for the detection of humoral tumor-specific immunity in BMC IMMUNOLOGY
  • 2008-12 Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides in BMC IMMUNOLOGY
  • 2008-12 A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers" in JOURNAL OF TRANSLATIONAL MEDICINE
  • 2008-02 Tumor stromal barriers to the success of adoptive T cell therapy in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2007-12 Phenotype and in vitrofunction of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors in JOURNAL OF IMMUNE BASED THERAPIES AND VACCINES
  • 2007-12 Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responses in BMC IMMUNOLOGY
  • 2007-03 CD4 regulatory T cells in human cancer pathogenesis in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2007 General Approaches to Measuring Immune Responses in GENERAL PRINCIPLES OF TUMOR IMMUNOTHERAPY
  • 2006-04 Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce “danger signals” in BREAST CANCER RESEARCH AND TREATMENT
  • 2006-04 Erratum to: Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce “danger signals” in BREAST CANCER RESEARCH AND TREATMENT
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.34477.33", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21107.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.284594.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1049.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416879.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.468198.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14095.39", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.458426.9", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4367.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.270240.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.11598.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21729.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.50956.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.224260.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.214007.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
          }
        ], 
        "familyName": "Disis", 
        "givenName": "Mary L", 
        "id": "sg:person.01165771723.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165771723.17"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:45", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_498.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01165771723.17'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01165771723.17'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01165771723.17'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01165771723.17'


     

    This table displays all metadata directly associated to this object as RDF triples.

    46 TRIPLES      10 PREDICATES      26 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01165771723.17 schema:affiliation N1c612714df814842a7c060301dbd440b
    2 https://www.grid.ac/institutes/grid.1049.c
    3 https://www.grid.ac/institutes/grid.11598.34
    4 https://www.grid.ac/institutes/grid.14095.39
    5 https://www.grid.ac/institutes/grid.21107.35
    6 https://www.grid.ac/institutes/grid.214007.0
    7 https://www.grid.ac/institutes/grid.21729.3f
    8 https://www.grid.ac/institutes/grid.224260.0
    9 https://www.grid.ac/institutes/grid.270240.3
    10 https://www.grid.ac/institutes/grid.284594.6
    11 https://www.grid.ac/institutes/grid.416879.5
    12 https://www.grid.ac/institutes/grid.4367.6
    13 https://www.grid.ac/institutes/grid.458426.9
    14 https://www.grid.ac/institutes/grid.468198.a
    15 https://www.grid.ac/institutes/grid.50956.3f
    16 https://www.grid.ac/institutes/grid.66875.3a
    17 schema:familyName Disis
    18 schema:givenName Mary L
    19 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165771723.17
    20 schema:sdDatePublished 2019-03-07T14:45
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher Na5c32265a82b48329a336697e206ca16
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset persons
    25 rdf:type schema:Person
    26 N1c612714df814842a7c060301dbd440b schema:affiliation https://www.grid.ac/institutes/grid.34477.33
    27 sgo:isCurrent true
    28 rdf:type schema:OrganizationRole
    29 Na5c32265a82b48329a336697e206ca16 schema:name Springer Nature - SN SciGraph project
    30 rdf:type schema:Organization
    31 https://www.grid.ac/institutes/grid.1049.c schema:Organization
    32 https://www.grid.ac/institutes/grid.11598.34 schema:Organization
    33 https://www.grid.ac/institutes/grid.14095.39 schema:Organization
    34 https://www.grid.ac/institutes/grid.21107.35 schema:Organization
    35 https://www.grid.ac/institutes/grid.214007.0 schema:Organization
    36 https://www.grid.ac/institutes/grid.21729.3f schema:Organization
    37 https://www.grid.ac/institutes/grid.224260.0 schema:Organization
    38 https://www.grid.ac/institutes/grid.270240.3 schema:Organization
    39 https://www.grid.ac/institutes/grid.284594.6 schema:Organization
    40 https://www.grid.ac/institutes/grid.34477.33 schema:Organization
    41 https://www.grid.ac/institutes/grid.416879.5 schema:Organization
    42 https://www.grid.ac/institutes/grid.4367.6 schema:Organization
    43 https://www.grid.ac/institutes/grid.458426.9 schema:Organization
    44 https://www.grid.ac/institutes/grid.468198.a schema:Organization
    45 https://www.grid.ac/institutes/grid.50956.3f schema:Organization
    46 https://www.grid.ac/institutes/grid.66875.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...